TRIPTORELIN PAMOATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for triptorelin pamoate and what is the scope of freedom to operate?
Triptorelin pamoate
is the generic ingredient in two branded drugs marketed by Azurity and Verity, and is included in four NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.Triptorelin pamoate has forty-six patent family members in thirty-one countries.
There are two drug master file entries for triptorelin pamoate. Two suppliers are listed for this compound.
Summary for TRIPTORELIN PAMOATE
International Patents: | 46 |
US Patents: | 1 |
Tradenames: | 2 |
Applicants: | 2 |
NDAs: | 4 |
Drug Master File Entries: | 2 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 56 |
Clinical Trials: | 17 |
Patent Applications: | 6,823 |
What excipients (inactive ingredients) are in TRIPTORELIN PAMOATE? | TRIPTORELIN PAMOATE excipients list |
DailyMed Link: | TRIPTORELIN PAMOATE at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for TRIPTORELIN PAMOATE
Generic Entry Date for TRIPTORELIN PAMOATE*:
Constraining patent/regulatory exclusivity:
Dosage:
INJECTABLE;INTRAMUSCULAR |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for TRIPTORELIN PAMOATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Janssen Pharmaceutica | Phase 2 |
Cancer Research Antwerp | Phase 2 |
Stanford University | Phase 1/Phase 2 |
Medical Subject Heading (MeSH) Categories for TRIPTORELIN PAMOATE
Anatomical Therapeutic Chemical (ATC) Classes for TRIPTORELIN PAMOATE
US Patents and Regulatory Information for TRIPTORELIN PAMOATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Verity | TRELSTAR | triptorelin pamoate | INJECTABLE;INTRAMUSCULAR | 022437-001 | Mar 10, 2010 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Azurity | TRIPTODUR KIT | triptorelin pamoate | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 208956-001 | Jun 29, 2017 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Verity | TRELSTAR | triptorelin pamoate | INJECTABLE;INTRAMUSCULAR | 020715-001 | Jun 15, 2000 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TRIPTORELIN PAMOATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Verity | TRELSTAR | triptorelin pamoate | INJECTABLE;INTRAMUSCULAR | 021288-001 | Jun 29, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Verity | TRELSTAR | triptorelin pamoate | INJECTABLE;INTRAMUSCULAR | 020715-001 | Jun 15, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Verity | TRELSTAR | triptorelin pamoate | INJECTABLE;INTRAMUSCULAR | 021288-001 | Jun 29, 2001 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for TRIPTORELIN PAMOATE
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | 5419169 | ⤷ Sign Up | |
Croatia | P20161785 | ⤷ Sign Up | |
New Zealand | 582423 | SLOW RELEASE PHARMACEUTICAL COMPOSITION MADE OF MICROPARTICLES COMPRISING PLGA, LHRH AND LACTIC ACID | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |